SPY336.83-0.61 -0.18%
DIA279.42-0.62 -0.22%
IXIC11,042.50+30.27 0.27%

Iterum Therapeutics Q3 EPS $(2.15) Down From $(1.24) YoY

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(2.15) per share. This is a 73.39 percent decrease over losses of $(1.24) per share from the same period last year.

Benzinga · -

Iterum Therapeutics (NASDAQ:ITRM) reported quarterly losses of $(2.15) per share. This is a 73.39 percent decrease over losses of $(1.24) per share from the same period last year.